5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

被引：865

作者：

Cardoso, F. ^{[1
]}

Paluch-Shimon, S. ^{[2
]}

Senkus, E. ^{[3
]}

Curigliano, G. ^{[4
]}

Aapro, M. S. ^{[5
]}

Andre, F. ^{[6
]}

Barrios, C. H. ^{[7
]}

Bergh, J. ^{[8
,9
]}

Bhattacharyya, G. S. ^{[10
]}

Biganzoli, L. ^{[11
]}

Boyle, F. ^{[12
]}

Cardoso, M-J ^{[1
,13
]}

Carey, L. A. ^{[14
]}

Cortes, J. ^{[15
,16
,17
]}

El Saghir, N. S. ^{[18
]}

Elzayat, M. ^{[19
]}

Eniu, A. ^{[20
]}

Fallowfield, L. ^{[21
]}

Francis, P. A. ^{[22
]}

Gelmon, K. ^{[23
]}

Gligorov, J. ^{[24
]}

Haidinger, R. ^{[25
]}

Harbeck, N. ^{[26
]}

Hu, X. ^{[27
]}

Kaufman, B. ^{[28
]}

Kaur, R. ^{[29
]}

Kiely, B. E. ^{[30
]}

Kim, S-B ^{[31
]}

Lin, N. U. ^{[32
]}

Mertz, S. A. ^{[33
]}

Neciosup, S. ^{[34
]}

Offersen, B., V ^{[35
]}

Ohno, S. ^{[36
]}

Pagani, O. ^{[37
]}

Prat, A. ^{[38
,39
,40
]}

Penault-Llorca, F. ^{[41
,42
]}

Rugo, H. S. ^{[43
]}

Sledge, G. W. ^{[44
]}

Thomssen, C. ^{[45
]}

Vorobiof, D. A. ^{[46
]}

Wiseman, T. ^{[47
]}

Xu, B. ^{[48
]}

Norton, L. ^{[49
]}

Costa, A. ^{[50
,51
]}

Winer, E. P. ^{[32
]}

机构：

[1] Champalimaud Fdn, Champalimaud Clin Ctr, Breast Unit, Lisbon, Portugal

[2] Hadassah Univ Hosp, Sharett Div Oncol, Jerusalem, Israel

[3] Med Univ Gdansk, Dept Oncol & Radiotherapy, Gdansk, Poland

[4] Univ Milan, European Inst Oncol, Dept Oncol & Hematooncol, Div Early Drug Dev,IRCCS, Milan, Italy

[5] Clin Genolier, Breast Ctr, Genolier, Switzerland

[6] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

[7] Grp Oncoclin, Latin Amer Cooperat Oncol Grp LACOG, Porto Alegre, RS, Brazil

[8] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden

[9] Univ Hosp, Stockholm, Sweden

[10] Salt Lake City Med Ctr, Dept Med Oncol, Kolkata, India

[11] Nuovo Osped Prato Ist Toscano Tumori, Dept Med Oncol, Prato, Italy

[12] Royal North Shore Hosp, Pam McLean Ctr, St Leonards, NSW, Australia

[13] Nova Med Sch, Lisbon, Portugal

[14] UNC Lineberger Comprehens Canc Ctr, Dept Hematol & Oncol, Chapel Hill, NC USA

[15] Quiron Grp, IOB Inst Oncol, Madrid, Spain

[16] Quiron Grp, IOB Inst Oncol, Barcelona, Spain

[17] Vall dHebron Inst Oncol, Dept Oncol, Barcelona, Spain

[18] Amer Univ Beirut, Dept Internal Med, Div Hematol Oncol, Med Ctr, Beirut, Lebanon

[19] European Breast Canc Coalit, Europa Donna, Milan, Italy

[20] Riviera Chablais Hosp, Interdisciplinary Oncol Serv SIC, Rennaz, Switzerland

[21] Univ Sussex, Brighton & Sussex Med Sch, SHORE C, Brighton, E Sussex, England

[22] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[23] BC Canc Agcy, Med Oncol Dept, Vancouver, BC, Canada

[24] Sorbonne Univ, AP HP, Breast Canc Expert Ctr, Univ Canc Inst, Paris, France

[25] Brustkrebs Deutschland eV, Munich, Germany

[26] Univ Munich LMU, Breast Ctr, Dept Obstet & Gynaecol, Munich, Germany

[27] Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China

[28] Sheba Med Ctr, Dept Oncol, Ramat Gan, Israel

[29] Breast Canc Welf Assoc Malaysia, Petaling Jaya, Malaysia

[30] Sydney Med Sch, NHMRC Clin Trials Ctr, Sydney, NSW, Australia

[31] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea

[32] Dana Farber Canc Inst, Susan Smith Ctr Womens Canc, Breast Oncol Ctr, Boston, MA 02115 USA

[33] Metastat Breast Canc Network, Inverness, IL USA

[34] Natl Inst Neoplast Dis, Dept Med Oncol, Lima, Peru

[35] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark

[36] Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan

[37] Geneva Univ Hosp, Med Sch, Geneva, Switzerland

[38] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain

[39] IDIBAPS, Translat Genom & Targeted Therapies Solid Tumors, Barcelona, Spain

[40] Univ Barcelona, Dept Med, Barcelona, Spain

[41] Ctr Jean Perrin, Dept Biopathol, Clermont Ferrand, France

[42] Univ Clermont Auvergne, INSERM U1240, Clermont Ferrand, France

[43] UCSF Helen Diller Family Comprehens Canc Ctr, Breast Oncol Clin Trials Educ, San Francisco, CA USA

[44] Stanford Sch Med, Div Oncol, Stanford, CA 94305 USA

[45] Martin Luther Univ Halle Wittenburg, Dept Gynaecol, Halle, Germany

[46] BelongLife, Oncol Res Unit, Tel Aviv, Israel

[47] Royal Marsden Hosp NHS Fdn Trust, Dept Appl Hlth Res Canc Care, London, England

[48] Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing, Peoples R China

[49] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, 1275 York Ave, New York, NY 10021 USA

[50] European Sch Oncol, Milan, Italy

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 12期

关键词：

ABC; advanced; breast cancer; ESO-ESMO; guidelines; metastatic; QUALITY-OF-LIFE; HORMONE REPLACEMENT THERAPY; MONARCH; ABEMACICLIB; PLUS FULVESTRANT; PHASE-III; POSTMENOPAUSAL WOMEN; MENOPAUSAL SYMPTOMS; VASOMOTOR SYMPTOMS; CONTROLLED-TRIAL; VAGINAL DRYNESS;

D O I：

10.1016/j.annonc.2020.09.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1623 / 1649

页数：27

共 50 条

[21] ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019 Commentary by the German panel of experts on the ABC5 voting results
Untch, Michael
Wuerstlein, Rachel
Lueftner, Diana
Haidinger, Renate
Fasching, Peter A.
Augustin, Doris
Briest, Susanne
Ettl, Johannes
Foerster, Frank
Kurbacher, Christian M.
Lueck, Hans-Joachim
Marschner, Norbert
Mueller, Lothar
Mueller, Volkmar
Radke, Isabel
Ruckhaeberle, Eugen
Scheffen, Iris
Schumacher-Wulf, Eva
Schwoerer, Moritz
Steinfeld-Birg, Dieter
Ziegler-Loehr, Katja
Thomssen, Christoph
Harbeck, Nadia
GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : 588 - 600
[22] 4th ESO-ESMO Breast Cancer in Young Women International Conference (BCY4), Lugano, Switzerland, October 6-8, 2018 Abstract
不详
BREAST, 2018, 41 : S1 - S32
[23] Lively Guidelines are in Demand Report from the 5th International Conference of the Guidelines International Network
Saenger, Sylvia
ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2008, 102 (10): : 678 - 680
[24] 5th International Conference on Advanced Particulate Materials and Processes
Froes, S
POWDER METALLURGY, 1997, 40 (02) : 114 - 116
[25] Adherence to International ESO-ESMO (ABC) guide-lines in HER2-ve metastatic breast cancer (MBC) patients (pts): Preliminary results of the GIM 13-AMBRA Study
Cazzaniga, M.
Mustacchi, G.
Giordano, M.
Garrone, O.
Donadio, M.
del Mastro, L.
Livi, L.
Natoli, C.
Michelotti, A.
Turletti, A.
Ferdinando, R.
De laurentiis, M.
Marchetti, P.
Montemurro, M.
Romagnoli, E.
De Placido, S.
Pronzato, P.
Biganzoli, L.
Bisagni, G.
Bria, E.
ANNALS OF ONCOLOGY, 2017, 28
[26] ABC3 Consensus Commented from the Perspective of the German Guidelines Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07.11.2015
Untch, M.
Augustin, D.
Ettl, J.
Haidinger, R.
Harbeck, N.
Lueck, H. -J.
Lueftner, D.
Marme, F.
Mueller, L.
Overkamp, F.
Ruckhaeberle, E.
Thill, M.
Thomssen, C.
Wuerstlein, R.
Marschner, N.
GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (02) : 156 - 163
[27] Breast cancer: The complete guide, 5th edition
Fox, Bette-Lee
LIBRARY JOURNAL, 2008, 133 (14) : 155 - 155
[28] 5th International IUPAC Conference on Green Chemistry (5th ICGC)
Mammino, Liliana
PURE AND APPLIED CHEMISTRY, 2016, 88 (1-2) : 1 - 2
[29] ANM2014: 5th International conference on Advanced Nanomaterials
Titus, Elby
Neto, Victor
MATERIALS TODAY-PROCEEDINGS, 2015, 2 (01) : V - V
[30] The 5th International Symposium on Advanced Technologies and Applications in the Internet of Things
Conference, Hybrid
CEUR Workshop Proceedings, 2023, 3459

← 1 2 3 4 5 →